Novavax News

That's a pitch I'm sure you've heard some semblance of at cocktail parties, golf outings, weddings, and, of course, on the Internet.

Several small-cap stocks were poised to move on above-average volume during Friday's session Novavax slipped by 3 cents, or 0.7%, to $4 after the company reported a third-quarter loss of 8 cents a share, a penny better than the Thomson Reuters average estimate.

While Novavax moves closer to commercializing its flu vaccines, it continues to lose money.

On this day, we have begun tracking the following companies as they have shown remarkable correction in recent days, you can access these free reports with a number of other reviews by signing up for your complimentary membership at: Penn West Energy Trust - Sector: Basic Materials Gerdau AmeriSteel Corp.

Stock-PR.com, a division of Crown Equity Holdings Inc. tracks stocks daily and is pleased to offer its hot stock alerts.

Biotechnology company Novavax Inc. said Monday its seasonal flu vaccine candidate met key goals in a midstage clinical trial.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 10/30/09, Covidien , a leading global provider of healthcare products, announced its subsidiary, Mallinckrodt Inc., has received U.S. Food and Drug Administration approval of its Abbreviated New Drug Application for Oral Transmucosal Fentanyl ...

CPL Biologicals Pvt. Ltd., a joint venture between biotechnology company Novavax Inc.

CPL Biologicals Pvt. Ltd., a joint venture between biotechnology company Novavax Inc.

Novavax, Inc. announced today that CPL Biologicals Pvt. Ltd., the new joint venture between Cadila Pharmaceuticals in India, has begun construction of a state-of-the-art manufacturing facility that will be used to produce pandemic and seasonal influenza vaccines.

Several small-cap stocks were poised to move on above-average volume during Wednesday's session Novavax rose by 7 cents, or 1.8%, to $3.92 in the premarket session after the company said it has entered into a strategic collaboration with Xcellerex to develop a large-scale manufacturing process for its 2009 H1N1 influenza VLP vaccine.

Novavax Inc. is partnering with a Mexican vaccine maker to run the Rockville biotech's largest clinical trials to date to test its vaccine technology against the pandemic H1N1 flu strain.

Novavax Inc. said Wednesday it will work with Xcellerex Inc. to increase production of a potential swine flu vaccine.

Interview with CEO Rahul Singhvi (InBusiness)

A vaccine for the 2009 H1N1 influenza virus made in insect cells could be approved in Mexico as early as next year.

Novavax Inc., the Rockville, Md., biotech company, said on Tuesday that it began a two-stage clinical study in Mexico of a vaccine for H1N1 influenza.

Two Maryland biotechnology firms began working feverishly in April to formulate swine flu vaccines - one through classic methods that produced a usable vaccine and the other with newer technology that could speed production in the face of a pandemic.

Weekly Digest , a free investment research publication, announced the publication of a special report on investment opportunities in connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for Alpha Pro Tech , Novavax , Generex Biotechnology , Inovio Biomedical , AstraZeneca and several others.

Dallas, TX - Sequenom, Inc. jumped up by 10.78% to close at $3.70 on a massive volume of 16.41 million shares after Sequenom yesterday announced that all its data is bogus.